1
Donald J Eaton, Mary L Moran, Rodney Brenneman: Sinus delivery of sustained release therapeutics. Sinexus, Morrison & Foerster, June 9, 2009: US07544192 (73 worldwide citation)

The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biod ...


2
Donald J Eaton, Thomas R Tice, David B Downie, Patrick A Arensdorf, Rodney Brenneman, Danielle L Biggs: Device and methods for treating paranasal sinus conditions. Intersect ENT, Morrison & Foerster, September 27, 2011: US08025635 (66 worldwide citation)

Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus ...


3
Donald J Eaton, Mary L Moran, Rodney Brenneman: Sinus delivery of sustained release therapeutics. Sinexus, Morrison & Foerster, March 30, 2010: US07686798 (51 worldwide citation)

The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biod ...


4
Donald J Eaton, Thomas R Tice, David B Downie, Patrick A Arensdorf, Rodney Brenneman, Danielle L Biggs: Device and methods for treating paranasal sinus conditions. Intersect ENT, Morrison & Foerster, December 25, 2012: US08337454 (44 worldwide citation)

Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus ...


5
Donald J Eaton, Mary Lynn Moran, Rodney A Brenneman: Sinus delivery of sustained release therapeutics. Intersect ENT, Morrison & Foerster, May 31, 2011: US07951132 (43 worldwide citation)

The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biod ...


6
Patrick A Arensdorf, Danielle L Biggs, Rodney Brenneman, David B Downie, Donald J Eaton, Thomas R Tice: Devices and methods for delivering active agents to the osteomeatal complex. Intersect ENT, Morrison & Foerster, September 17, 2013: US08535707 (31 worldwide citation)

Described here are devices, methods, and kits for treating sinusitis and related respiratory conditions by locally delivering active agents to the osteomeatal complex over a sustained period of time. The devices may be passively fixed within the osteomeatal complex and/or include one or more feature ...


7
Donald J Eaton, Mary L Moran, Rodney Brenneman: Sinus delivery of sustained release therapeutics. Intersect ENT, Morrison & Foerster, May 11, 2010: US07713255 (27 worldwide citation)

The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biod ...


8
Donald J Eaton, Thomas R Tice, David B Downie, Patrick A Arensdorf, Rodney A Brenneman, Danielle L Biggs: Device and methods for treating paranasal sinus conditions. Intersect ENT, Morrison & Foerster, June 3, 2014: US08740839 (23 worldwide citation)

Described here are paranasal sinus devices for treating paranasal sinus conditions. The devices include a cavity member, ostial member, and nasal portion. One or more of the cavity member, ostial member, and nasal portion may deliver an active agent for sustained release to treat the paranasal sinus ...


9
Donald J Eaton, Mary L Moran, Rodney Brenneman: Sinus delivery of sustained release therapeutics. Sinexus, Morrison & Foerster, February 16, 2010: US07662142 (23 worldwide citation)

The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biod ...


10
Donald J Eaton, Mary L Moran, Rodney Brenneman: Sinus delivery of sustained release therapeutics. Sinexus, Morrison & Foerster, February 16, 2010: US07662141 (22 worldwide citation)

The invention provides biodegradable implants for treating sinusitis. The biodegradable implants have a size, shape, density, viscosity, and/or mucoadhesiveness that prevents them from being substantially cleared by the mucociliary lining of the sinuses during the intended treatment period. The biod ...